Chemically, it is a decarboxylase inhibitor. Carbidopa does not directly treat the symptoms of Parkinsons disease but enhances the effectiveness of levodopa, a precursor to dopamine. By inhibiting the conversion of levodopa into dopamine outside the brain, carbidopa allows more levodopa to reach the brain, where it can be converted into dopamine. This helps alleviate the motor symptoms associated with Parkinsons diseaseBuy high quality Carbidopa from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Carbidopa